Search results for "RC666-701"

showing 10 items of 122 documents

Clinical profiles and quality of care of subjects with type 2 diabetes according to their cardiovascular risk: an observational, retrospective study

2021

Abstract Background The European Society of Cardiology (ESC) recently defined cardiovascular risk classes for subjects with diabetes. Aim of this study was to explore the distribution of subjects with type 2 diabetes (T2D) by cardiovascular risk groups according to the ESC classification and to describe the quality indicators of care, with particular regard to cardiovascular risk factors. Methods The study is based on data extracted from electronic medical records of patients treated at the 258 Italian diabetes centers participating in the AMD Annals initiative. Patients with T2D were stratified by cardiovascular risk. General descriptive indicators, measures of intermediate outcomes, inten…

AdultBlood GlucoseMalelcsh:Diseases of the circulatory (Cardiovascular) systemmedicine.medical_specialtyTime FactorsEndocrinology Diabetes and MetabolismType 2 diabetesIncretinsRisk AssessmentDiabetes mellitusInternal medicinemedicineElectronic Health RecordsHumansHypoglycemic AgentsMedical prescriptionSodium-Glucose Transporter 2 InhibitorsOriginal InvestigationAgedQuality Indicators Health CareRetrospective StudiesAngiologyCardiovascular risk Humans Hypoglycemic Agents Incretins Italy Male Middle Aged Retrospective Studies Risk Assessment Sodium-Glucose Transporter 2 Inhibitors Time Factors Treatment Outcome Quality Indicators Health Care Quality of care Type 2 diabetes Adult Aged Aged 80 and over Biomarkers Blood Glucose Cardiovascular Diseases Diabetes Mellitus Type 2 Dipeptidyl-Peptidase IV Inhibitors Heart Disease Risk Factors Female Electronic Health RecordsAged 80 and overDipeptidyl-Peptidase IV Inhibitorsbusiness.industryMedical recordQuality of careType 2 diabetesRetrospective cohort studyMiddle AgedCardiovascular riskmedicine.diseaseTreatment OutcomeDiabetes Mellitus Type 2ItalyCardiovascular DiseasesHeart Disease Risk Factorslcsh:RC666-701AlbuminuriaFemaleObservational studymedicine.symptomCardiology and Cardiovascular MedicinebusinessBiomarkersCardiovascular Diabetology
researchProduct

Evaluation of Hypertension, Proteinuria, and Abnormalities of Body Weight in Italian Adolescents Participating in the World Kidney Days

2020

Introduction: World Kidney Day (WKD) was promoted by the Italian Kidney Foundation and the Italian Society of Nephrology for raising awareness, detection, prevention, and treatment of kidney diseases. The Italian WKD focused on the “School Project” by screening students attending the fifth year of high school. The main goal of the “School Project” was to assess in healthy adolescents the presence of hypertension (HTN) and proteinuria; as well as to evaluate potential interrelations between overweight, obesity (both measured with different anthropometric methods), blood pressure (BP) levels, and proteinuria. The ancillary goal was to have an estimate of awareness on some nephrology topics. M…

AdultMaleAdolescents; Anthropometric indicators; BMI; Hypertension; Obesity; Proteinurialcsh:Diseases of the circulatory (Cardiovascular) systemmedicine.medical_specialtyWaistAdolescentAnthropometric indicators · BMI · Proteinuria · Hypertension · Obesity · Adolescents030232 urology & nephrologyOverweightKidneylcsh:RC870-923Young AdultBMI03 medical and health sciencesanthropometric indicators0302 clinical medicineRisk FactorsInternal medicinelcsh:DermatologyAnthropometric indicatormedicineHumansadolescentsObesitycardiovascular diseasesProteinuriabusiness.industryBody WeightGeneral Medicinelcsh:RL1-803Anthropometrylcsh:Diseases of the genitourinary system. Urologymedicine.diseaseObesityBlood pressureItalylcsh:RC666-701NephrologyHypertensionProteinuria.FemaleproteinuriaUnderweightmedicine.symptomCardiology and Cardiovascular MedicinebusinessBody mass indexKidney and Blood Pressure Research
researchProduct

Heart and Skeletal Muscles: Linked by Autonomic Nervous System.

2019

Background Resting sympathetic hyperactivity and impaired parasympathetic reactivation after exercise have been described in patients with heart failure (HF). However, the association of these autonomic changes in patients with HF and sarcopenia is unknown. Objective The aim of this study was to evaluate the impact of autonomic modulation on sarcopenia in male patients with HF. Methods We enrolled 116 male patients with HF and left ventricular ejection fraction < 40%. All patients underwent a maximal cardiopulmonary exercise testing. Maximal heart rate was recorded and delta heart rate recovery (∆HRR) was assessed at 1st and 2nd minutes after exercise. Muscle sympathetic nerve activity (MSN…

AdultMaleMuscleSkeletallcsh:Diseases of the circulatory (Cardiovascular) systemSarcopeniaSympathetic Nervous Systemheart failurelihaksetBioinformaticsAutonomic Nervous SystemsarcopeniaYoung AdultOxygen ConsumptionHeart Ratehomeostasisautonominen hermostomedicinemyocardiumHomeostasisHumansBlunted Vagal Reactivation.Muscle StrengthsydäntauditMuscle SkeletalAgedsympathetic nervous systemSympathetica Nervous SystemHeart FailureHand Strengthbusiness.industryMyocardiumautonomic nervous systemHeartMiddle Agedmedicine.diseaseAutonomic nervous systemSympathetic Hyperactivitylcsh:RC666-701Heart failureSarcopeniaExercise TestOriginal Articlemuscle skeletalShort EditorialCardiology and Cardiovascular Medicinebusinesshuman activitiesHomeostasislihasvoimaArquivos brasileiros de cardiologia
researchProduct

Long term hemodialysis aggravates lipolytic activity reduction and very low density, low density lipoproteins composition in chronic renal failure pa…

2009

Abstract Background Dyslipidemia, particularly hypertriglyceridemia is common in uremia, and represents an independent risk factor for atherosclerosis. Methods To investigate the effects of hemodialysis (HD) duration on very low density lipoprotein (VLDL) and low density lipoprotein (LDL) compositions and lipopolytic activities, 20 patients on 5 to 7 years hemodialysis were followed-up during 9 years. Blood samples were drawn at T0 (beginning of the study), T1 (3 years after initiating study), T2 (6 years after initiating study) and T3 (9 years after initiating study). T0 was taken as reference. Results Triacylglycerols (TG) values were correlated with HD duration (r = 0.70, P Conclusion De…

AdultMalelcsh:Diseases of the circulatory (Cardiovascular) systemVery low-density lipoproteinmedicine.medical_specialtyTime Factorsmedicine.medical_treatmentLipolysisBlood lipidsLipoproteins VLDLRisk Assessmentchemistry.chemical_compoundRenal DialysisRisk FactorsInternal medicinemedicineHumansInsulinLongitudinal StudiesTriglyceridesDyslipidemiasLipoprotein lipaseApolipoprotein C-IIICholesterolbusiness.industryHypertriglyceridemianutritional and metabolic diseasesLipaseMiddle Agedmedicine.diseaseAtherosclerosisLipoproteins LDLLipoprotein LipaseEndocrinologyCholesterolchemistrylcsh:RC666-701Low-density lipoproteinLinear ModelsKidney Failure Chroniclipids (amino acids peptides and proteins)Apolipoprotein C-IIFemaleHepatic lipaseHemodialysisCardiology and Cardiovascular MedicinebusinessBiomarkersResearch ArticleBMC cardiovascular disorders
researchProduct

Association between a comprehensive smoking ban and hospitalization for acute myocardial infarction: An observational study in the Autonomous Communi…

2020

Objective: To assess the association between a comprehensive smoking ban and hospitalization rates for acute myocardial infarction (AMI). Methods: An observational study was conducted to assess changes in hospital admission rates for AMI in the Autonomous Community of Valencia, Spain (population 5 million), during the period 1995-2013. Law 28/2005 prohibited smoking in all enclosed spaces (public and private), and Law 42/2010 extended the ban to bars and restaurants as well as children's playgrounds and access areas of schools and hospitals. Data on hospital admissions were obtained from the Hospital Discharge Database (CMBD) of the Autonomous Community. Annual hospital admission rates per …

AdultMalemedicine.medical_specialtylcsh:Diseases of the circulatory (Cardiovascular) systemPopulationEnfarte do miocárdio/prevenção e controloMyocardial InfarctionAdmissão de doentes03 medical and health sciencesYoung Adult0302 clinical medicineCessação tabágica/legislação e jurisprudênciaPolítica de saúdeHealth careSocietal perspectivemedicineHumans030212 general & internal medicineMyocardial infarctioneducationhealth care economics and organizationsGeneral Environmental ScienceAgedAged 80 and overeducation.field_of_studybusiness.industryHospital discharge databaseMiddle Agedmedicine.diseaseHospitalizationSmoke-Free Policy030228 respiratory systemTabagismo/prevenção e controloSpainlcsh:RC666-701Hospital admissionEmergency medicineGeneral Earth and Planetary SciencesObservational studyFemaleSmoking banCardiology and Cardiovascular MedicinebusinessRevista Portuguesa de Cardiologia
researchProduct

Sex differences on peak oxygen uptake in heart failure

2019

Women represent nearly half of the adult heart failure (HF) population and they remain underrepresented in HF studies. We aimed to evaluate the evidence about peak oxygen uptake (peak VO2) for clinical stratification in women with HF. This narrative review summarizes (i) the evidence endorsing the value of cardiopulmonary exercise testing for clinical stratification and phenotyping HF population; (ii) the determinants of a person’s functional aerobic capacity to understand predicted values for patients with chronic HF; and (iii) sex differences on peak VO2 data in different forms of HF. Lastly, based on existing data in patients with HF, we provide a perspective on how to improve existing g…

Adultlcsh:Diseases of the circulatory (Cardiovascular) systemmedicine.medical_specialtyPopulationReviewsHeart failureReview030204 cardiovascular system & hematologyRisk Assessment03 medical and health sciencesOxygen Consumption0302 clinical medicineInternal medicineSex differencesmedicineHumansIn patient030212 general & internal medicineeducationPeak oxygen uptakeAerobic capacityAgedAged 80 and overHeart FailureSex Characteristicseducation.field_of_studyExercise ToleranceEjection fractionbusiness.industryVO2 maxStroke VolumeMiddle AgedPrognosisClinical stratificationmedicine.diseaseOxygenPhenotypelcsh:RC666-701Heart failureExercise TestCardiologyFemaleGender gapCardiology and Cardiovascular MedicineRisk assessmentbusinessESC Heart Failure
researchProduct

Matrix Metalloproteases in Arterial Hypertension and their Trend after Antihypertensive Treatment

2017

&lt;b&gt;&lt;i&gt;Background/Aims&lt;/i&gt;&lt;/b&gt;&lt;b&gt;&lt;i&gt;:&lt;/i&gt;&lt;/b&gt; Arterial hypertension is characterized by vascular remodelling, atherosclerosis and cardiovascular complications. Matrix metalloproteases (MPPs) are endopeptidases produced by all the cells present in the vascular wall and are involved in the regulation of the extracellular matrix protein turnover. MMPs contribute to blood vessel formation, remodelling, angiogenesis; whereas an altered expression or activity of MMPs or their tissue inhibitors (TIMPs) results correlated with the development and progression of cardiovascular complications. &lt;b&gt;&lt;i&gt;Methods:&lt;/i&gt;&lt;/b&gt; We examined the…

Arterial hypertensionVascular remodelling0301 basic medicinelcsh:Diseases of the circulatory (Cardiovascular) systemmedicine.medical_specialtyAngiogenesisMatrix metalloproteasesMatrix metalloproteaseHemodynamics030204 cardiovascular system & hematologyPharmacologyMatrix metalloproteinaselcsh:RC870-923Vascular remodelling in the embryoExtracellular matrix03 medical and health scienceschemistry.chemical_compound0302 clinical medicineFibrosisInternal medicinelcsh:DermatologymedicineHumansAntihypertensive AgentsAldosteronebusiness.industryTissue Inhibitor of MetalloproteinasesGeneral Medicinelcsh:RL1-803lcsh:Diseases of the genitourinary system. Urologymedicine.diseaseMatrix Metalloproteinases030104 developmental biologymedicine.anatomical_structurechemistrylcsh:RC666-701Cardiovascular DiseasesNephrologyHypertensionCardiologyArterial hypertension; Matrix metalloproteases; Vascular remodelling; Cardiology and Cardiovascular Medicine; NephrologyCardiology and Cardiovascular MedicinebusinessBlood vesselKidney and Blood Pressure Research
researchProduct

Efficacy of dulaglutide on vascular health indexes in subjects with type 2 diabetes: a randomized trial

2021

Abstract Background Recent cardiovascular outcome trials have shown significant reductions in major cardiovascular (CV) events with glucagon-like peptide (GLP)-1 receptor agonists. Additionally, adjunctive surrogates for cardiovascular risk validated by some studies include arterial stiffness and endothelial function indexes. To date, no randomized trial has addressed the possible effects of antidiabetic interventional drugs such as GLP1 agonists on endothelial and arterial stiffness indexes as surrogate markers of vascular damage. Aims We aimed to evaluate metabolic efficacy and surrogate vascular efficacy endpoints of once-weekly dulaglutide (1.5 mg) plus traditional antidiabetic treatmen…

Blood GlucoseMalelcsh:Diseases of the circulatory (Cardiovascular) systemSettore MED/09 - Medicina InternaTime FactorsEndocrinology Diabetes and MetabolismGlucagon-Like PeptidesBlood PressureType 2 diabetesGastroenterologylaw.inventionRandomized controlled triallawPulse wave velocityOriginal InvestigationDiabetesMiddle AgedLipidsVasodilationTreatment OutcomeItalyDrug Therapy CombinationFemaleCardiology and Cardiovascular Medicinemedicine.drugmedicine.medical_specialtyRecombinant Fusion ProteinsIncretinsGlucagon-Like Peptide-1 ReceptorVascular StiffnessDiabetes mellitusInternal medicinemedicineHumansHypoglycemic AgentsDulaglutideAngiologyAgedVascular healthGlycated Hemoglobinbusiness.industrymedicine.diseasedulaglutide diabetes arterial stiffnessImmunoglobulin Fc FragmentsBlood pressureDiabetes Mellitus Type 2lcsh:RC666-701Arterial stiffnessDulaglutidebusinessBiomarkersCardiovascular Diabetology
researchProduct

Associations of the FTO rs9939609 and the MC4R rs17782313 polymorphisms with type 2 diabetes are modulated by diet, being higher when adherence to th…

2012

Background: Although the Fat Mass and Obesity (FTO) and Melanocortin-4 Receptor (MC4R) genes have been consistently associated with obesity risk, the association between the obesity-risk alleles with type 2 diabetes is still controversial. In some recent meta-analyses in which significant results have been reported, the associations disappeared after adjustment for body mass index (BMI). However gene-diet interactions with dietary patterns have not been investigated. Our main aim was to analyze whether these associations are modulated by the level of adherence to the Mediterranean Diet (MedDiet). Methods: Case-control study in 7,052 high cardiovascular risk subjects (3,430 type 2 diabetes c…

Blood GlucoseMalelcsh:Diseases of the circulatory (Cardiovascular) systemmodelos logísticoscumplimiento del pacienteMediterranean dietEndocrinology Diabetes and MetabolismhumanosType 2 diabetesfrecuencia génicaMC4RDiet MediterraneanBody Mass IndexNutrigenomicsGene FrequencySurveys and QuestionnairesOdds Ratiomediana edadNutrigeneticsOriginal InvestigationAged 80 and overeducation.field_of_studyancianonutrigenómicaDiabetisdietamodelos linealesDiabetesayunodistribución de la ji al cuadradoFastingMiddle Agedcociente de probabilidades relativasestado nutricionalPhenotypeinteracción gen-ambientediabetes mellitusfenotipoReceptor Melanocortin Type 4FemaleDietaCardiology and Cardiovascular MedicineFTONutrigenòmicamedicine.medical_specialtyglucosa sanguíneaGene-diet interactionsPopulationestudios de casos y controlesAlpha-Ketoglutarate-Dependent Dioxygenase FTONutritional StatusDiabetes mellitusInternal medicineMediterranean dietmedicineGenetic predispositionHumansGenetic Predisposition to Diseaseanálisis multifactorialeducationAgedChi-Square DistributionPolymorphism Geneticbusiness.industryproteínasíndice de masa corporalCase-control studyProteinsnutritional and metabolic diseasespredisposición genética a la enfermedadmedicine.diseaseObesityDietEndocrinologyLogistic ModelsDiabetes Mellitus Type 2lcsh:RC666-701SpainCase-Control StudiesMultivariate AnalysisLinear ModelsPatient ComplianceGene-Environment InteractionbusinessBody mass index
researchProduct

Unrecognised cardiovascular disease in type 2 diabetes: is it time to act earlier?

2018

Abstract Cardiovascular disease (CVD) is the most significant prognostic factor in individuals with type 2 diabetes (T2D). However, a significant number of individuals may develop CVD that does not present with the classic angina-related or heart failure symptoms. In these cases, CVD may seem to be ‘silent’ or ‘asymptomatic’, but may be more accurately characterised as unrecognised diabetic cardiac impairment. An initial step to raise awareness of unrecognised CVD in individuals with T2D would be to reach a consensus regarding the terminology used to describe this phenomenon. By standardising the terminologies, and agreeing on the implementation of an efficient screening program, it is anti…

Blood Glucoselcsh:Diseases of the circulatory (Cardiovascular) systemEndocrinology Diabetes and Metabolism10265 Clinic for Endocrinology and DiabetologyDiseaseType 2 diabetes030204 cardiovascular system & hematologySilent0302 clinical medicineRisk FactorsMass ScreeningAsymptomatic ; Atypical ; Cardiovascular disease ; Screening ; Silent ; Type 2 diabetes ; Unrecognised.Type 2 diabetesCardiovascular diseasePrognosisAsymptomatic3. Good health2712 Endocrinology Diabetes and MetabolismCardiovascular DiseasesScreeningmedicine.symptomCardiology and Cardiovascular Medicinemedicine.medical_specialtyPrognostic factor030209 endocrinology & metabolism610 Medicine & healthRisk AssessmentAsymptomatic2705 Cardiology and Cardiovascular Medicine03 medical and health sciencesPredictive Value of TestsInternal medicineDiabetes mellitusmedicineHumansHypoglycemic AgentsIntensive care medicineUnrecognisedbusiness.industrymedicine.diseaseEarly DiagnosisDiabetes Mellitus Type 2lcsh:RC666-7012724 Internal MedicineHeart failureAsymptomatic DiseasesCommentarybusinessAtypicalBiomarkers
researchProduct